Oxytocic Pharmaceuticals Market Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Oxytocic Pharmaceuticals Market
Oxytocic medications that
increase uterine activity additionally, it controls postpartum haemorrhage. It
can be infused into a vein or injected into a muscle. By taking an extract from
an animal's pituitary gland, natural oxytocin can be created.
Over the projected period, an
increase in childbirths induced by labour is anticipated to fuel market
expansion for oxytocic medications. For instance, the National Perinatal
Information Center reported in January 2019 that induction of labour rates
increased by 40% in the United States between 1997 and 2017. Additionally, an
increased occurrence of postpartum haemorrhage is anticipated to support market
expansion.
The expansion of the worldwide
oxytocic pharmaceuticals market is anticipated to be hampered by the accessibility
of substitute medications. Misoprostol and magnesium sulphates are a few of
oxytocic drug substitutes. Misoprostol is advised by the World Health
Organization (WHO) as a low-cost, scientifically supported substitute for
oxytocin. Additionally, it is anticipated that oxytocin preparation quality
problems may impede market expansion. A number of producers fail to get WHO
prequalification before producing oxytocin products, which results in the
market introduction of medications of inferior quality.
Comments
Post a Comment